Central Nervous System Drugs Market Research Reports
Title | published | price | |
---|---|---|---|
Osteoarthritis Pain (Central Nervous System) - Drugs In Development, 2021By Global Markets Direct "...... Nervous System) pipeline landscape.
Osteoarthritis pain is the most common symptom associated with osteoarthritis which causes disruption of the cartilage. If the condition worsens, it leads to rubbing of the bones against each other cau......" | 30-Jul-2021 | $2000 | |
Binge Eating Disorder (Central Nervous System) - Drugs In Development, 2021By Global Markets Direct "...... ntral Nervous System) pipeline landscape.
Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain. The causes of binge-eating disorder are unknown. But family history, biological fact......" | 30-Jul-2021 | $2000 | |
Anesthetic Effect (Central Nervous System) - Drugs In Development, 2021By Global Markets Direct "...... s System) pipeline landscape.
Anesthetic effect causes a loss of consciousness. The factors that can increase risk of complications include smoking, obstructive sleep apnea, obesity, high blood pressure, history of adverse reactions to a......" | 30-Jul-2021 | $2000 | |
Mild Cognitive Impairment (Central Nervous System) - Drugs In Development, 2021By Global Markets Direct "...... pairment (Central Nervous System) pipeline landscape.
Mild cognitive impairment (MCI) is a condition involving problems with cognitive function (such as thinking, knowing and remembering). MCI is an intermediate stage between the expecte......" | 30-Jul-2021 | $2000 | |
Neuromyelitis Optica (Devic's Syndrome) (Central Nervous System) - Drugs In Development, 2021By Global Markets Direct "...... litis Optica (Central Nervous System) pipeline landscape.
Neuromyelitis optica (NMO), also known as Devic's disease, is an uncommon neurological condition caused by disease or damage to the brain, spinal cord or nerves. NMO is an autoimm......" | 30-Jul-2021 | $2000 | |
Dyskinesia (Central Nervous System) - Drugs In Development, 2021By Global Markets Direct "...... ndscape.
Dyskinesia refers to the involuntary nature of muscular movements or the difficulty in performing voluntary muscular movement. Symptoms include facial grimacing, finger movement, jaw swinging, repetitive chewing and tongue thrus......" | 30-Jul-2021 | $2000 | |
Friedreich Ataxia (Central Nervous System) - Drugs In Development, 2021By Global Markets Direct "...... s System) pipeline landscape.
Friedreich's ataxia (FA) is a neuromuscular disease that mainly affects the nervous system and the heart. FA is a hereditary disease, caused by a defective gene that can be passed down through a family. Sign......" | 30-Jul-2021 | $2000 | |
Opium (Opioid) Addiction (Central Nervous System) - Drugs In Development, 2021By Global Markets Direct "...... ction (Central Nervous System) pipeline landscape.Opioid Addiction develops after using opioids regularly for a period of time. Prolonged use of opiates can lead to nerve damage within the brain that causes cells to stop producing endogenous opiates ......" | 30-Jul-2021 | $2000 | |
Depression (Central Nervous System) - Drugs In Development, 2021By Global Markets Direct "...... ndscape.
Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest. Signs and symptoms include sleep disturbances, including insomnia or sleeping too much, changes in appetite, anxiety, agitation or r......" | 30-Jul-2021 | $2500 | |
Rett Syndrome (Central Nervous System) - Drugs In Development, 2021By Global Markets Direct "...... peline landscape.
Rett syndrome is a neurodevelopmental disorder. This is caused by genetic mutation on MECP2 gene. Rett syndrome is described in four stages: Stage I or early onset, Stage II or rapid destruction, Stage III, or the plate......" | 30-Jul-2021 | $2000 | |
|